Daihan Pharmaceutical Revenue vs. Return On Equity
| 023910 Stock | KRW 26,150 400.00 1.51% |
For Daihan Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Daihan Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Daihan Pharmaceutical CoLtd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Daihan Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Daihan Pharmaceutical CoLtd over time as well as its relative position and ranking within its peers.
Daihan |
Daihan Pharmaceutical Return On Equity vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Daihan Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Daihan Pharmaceutical value to that of its competitors to determine the firm's financial worth. Daihan Pharmaceutical CoLtd is the top company in revenue category among its peers. It also is number one stock in return on equity category among its peers . The ratio of Revenue to Return On Equity for Daihan Pharmaceutical CoLtd is about 13,727,126,151 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Daihan Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Daihan Pharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Daihan Revenue vs. Competition
Daihan Pharmaceutical CoLtd is the top company in revenue category among its peers. Market size based on revenue of Pharmaceuticals industry is presently estimated at about 690.28 Billion. Daihan Pharmaceutical totals roughly 171.46 Billion in revenue claiming about 25% of equities listed under Pharmaceuticals industry.
Daihan Return On Equity vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Daihan Pharmaceutical |
| = | 171.46 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Daihan Pharmaceutical |
| = | 12.49 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Daihan Return On Equity Comparison
Daihan Pharmaceutical is currently under evaluation in return on equity category among its peers.
Daihan Pharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Daihan Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Daihan Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of Daihan Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of Daihan Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
,Ltd. manufactures and sells various medicinal products in South Korea. ,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. DaihanPharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
Daihan Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Daihan Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Daihan Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Daihan Pharmaceutical's important profitability drivers and their relationship over time.
Use Daihan Pharmaceutical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Daihan Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daihan Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Daihan Pharmaceutical Pair Trading
Daihan Pharmaceutical CoLtd Pair Trading Analysis
The ability to find closely correlated positions to Daihan Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Daihan Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Daihan Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Daihan Pharmaceutical CoLtd to buy it.
The correlation of Daihan Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Daihan Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Daihan Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Daihan Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Daihan Pharmaceutical position
In addition to having Daihan Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Theme ETFs Thematic Idea Now
Theme ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Theme ETFs theme has 484 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Theme ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Daihan Stock
To fully project Daihan Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Daihan Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Daihan Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.